Redwood Trust (RWT US)
RWT US$3.26
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 3.26
- Change
- ▲ 0.02 (0.62)
- Bid / Ask
- 3.27 - 3.28
- Volume
- 741,432
- Turnover
- 2,340,964
- Open
- 3.21
- Day Range
- 3.21 - 3.31
- VWAP
- 3.27
- Prev Close
- 3.24
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Real Estate
- Shares Issued
- 125,612,432
- NTA/Share
- 7.62
- Last Dividend
- 0.18
- Dividend Ex Date
- 23 SEP 2026
- Dividend Pay Date
- 30 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 130.97
- EBITDA
- —
- Profit
- -82.68
- Earnings Per Share (EPS)
- -0.63
- Dividend Per Share (DPS)
- 0.72
- Yield %
- 22.64
- Market Cap
- 409.50
- Price to Earnings Ratio (P/E)
- -54.33
Estimates (USD) · FY2026
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 298.89
- EBITDA
- —
- Profit
- 116.52
- Earnings Per Share (EPS)
- 1.00
- Dividend Per Share (DPS)
- 0.72
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 2.93 Fair value 4.39 One-star price 6.59
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 4.39
- Price / Fair Value
- 0.72
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 23 OCT 2026. The slider runs from the five-star price (2.93) to the one-star price (6.59).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 3.18 |
| Price - 12 month high | 6.97 |
| Price - 12 month low | 2.88 |
| Pricing date | 22 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 2.95 |
| Market capitalization | 399.45 |
| 12 Month High price date | 12 FEB 2026 |
| 12 Month Low price date | 19 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 4.12 |
| Price - 1 Day % Change | 1.92% |
| Price - 13 week price percent change | -35.10% |
| Price - 26 week price percent change | -44.21% |
| Price - 5 Day % Change | 4.61% |
| Price - 52 week price percent change | -43.72% |
| Price - YTD price percent change | -42.50% |
| Price % Change Month To Date | -14.52% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | -0.630 |
| EPS excluding extraordinary items - trailing 12 month | -0.050 |
| EPS Normalized - most recent fiscal year | -0.526 |
| Revenue/share - most recent fiscal year | 1.006 |
| Revenue/share - trailing 12 month | 1.675 |
| Book value per share - most recent fiscal year | 7.357 |
| Book value per share - most recent quarter | 6.902 |
| Book value (tangible) per share - most recent fiscal year | 7.622 |
| Book value (tangible) per share - most recent quarter | 6.543 |
| Cash per share - most recent fiscal year | 2.054 |
| Cash per share - most recent quarter | 1.527 |
| Cash Flow per share - most recent fiscal year | -78.158 |
| Cash Flow per share - trailing 12 month | -112.791 |
| Dividend per share - most recent fiscal year | 0.720 |
| Dividends per share - trailing 12 month | 0.720 |
| EBITD per share - trailing 12 month | — |
| EPS Basic excluding extraordinary items - most recent fiscal year | -0.630 |
| EPS Basic excluding extraordinary items - trailing 12 month | -0.050 |
| EPS including extraordinary items - most recent fiscal year | -0.630 |
| EPS including extraordinary items - trailing 12 month | -0.050 |
| Free Cash Flow per share - trailing 12 month | -112.791 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | — |
| P/E Normalized, most recent fiscal year | 49.09 |
| Price to sales - most recent fiscal year | 1.90 |
| Price to Tangible Book - most fiscal year | 0.53 |
| Price to Free Cash Flow per Share - most recent fiscal year | — |
| Price to Cash Flow per share - trailing 12 month | — |
| Price to Book - most recent fiscal year | 0.46 |
| P/E excluding extraordinary items high, trailing 12 months | — |
| P/E excluding extraordinary items low, trailing 12 months | — |
| Net Debt, LFI | 27,155.16 |
| Net Debt, LFY | 21,907.51 |
| Dividend Yield - 5 Year Average | 10.71% |
| Dividend Yield - indicated annual dividend divided by closing price | 23.08% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 22.64% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | -10,180.06 |
| LT debt/equity - most recent fiscal year | — |
| Payout ratio - most recent fiscal year | -114.29% |
| Total debt/total equity - most recent fiscal year | 2,255.53% |
| LT debt/equity - most recent quarter | — |
| Total debt/total equity - most recent quarter | 2,928.45% |
| Free Cash Flow - trailing 12 month | -14,249.20 |
| Payout ratio - trailing 12 month | -1,540.00% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 130.97 |
| Revenue - trailing 12 month | 211.56 |
| EBITD - most recent fiscal year | — |
| EBITD - trailing 12 month | — |
| Earnings before taxes - most recent fiscal year | -44.84 |
| Earnings before taxes - trailing 12 month | 18.72 |
| Net Income available to common - most recent fiscal year | -82.68 |
| Net Income available to common - trailing 12 months | -9.66 |
| Earnings before taxes Normalized - most recent fiscal year | -27.67 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.06 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | -53.47% |
| Net Profit Margin % - trailing 12 month | 2.70% |
| Operating margin - 1st historical fiscal year | — |
| Operating margin - trailing 12 month | — |
| Pretax margin - trailing 12 month | 8.85% |
| Pretax margin - 1st historical fiscal year | -34.24% |
| Operating Margin - 5 year average | — |
| Pretax Margin - 5 year average | 15.74% |
| Free Operating Cash Flow/Revenue, 5 Year Average | -3,463.74% |
| Free Operating Cash Flow/Revenue, TTM | -6,735.33% |
| Net Profit Margin - 5 year average | 7.65% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | -0.33% |
| Return on average assets - trailing 12 month | 0.02% |
| Return on average equity - most recent fiscal year | -6.90% |
| Return on average equity - trailing 12 month | 0.62% |
| Return on average assets - 5 year average | 0.18% |
| Return on average equity - 5 year average | 0.83% |
| Net Income/employee - most recent fiscal year | -199,504.27 |
| Revenue/employee - most recent fiscal year | 373,131.05 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | — |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | -7.85% |
| Revenue/share (5 yr growth) | — |
| Growth rate% - Revenue, 3 year | — |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | -5.79% |
| Capital Spending growth rate, 5 year | — |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | — |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | ||||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
